Fall Risk Assessment in Parkinson's Disease Using Kinetikos Health

ConditionIdiopathic Parkinsonism

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age20+

SponsorTaipei Medical University Shuang Ho Hospital

About this trial

This is a single-center, prospective observational study aiming to validate the Kinetikos Health App for fall risk assessment in PD patients undergoing dopaminergic medication adjustments.

Eligibility criteria

Qualifiers

Age ≥20;

PD diagnosis (MDS criteria);

On levodopa monotherapy with motor fluctuations;

Planned to start opicapone or safinamide;

Disqualifiers

Atypical/secondary parkinsonism;

Moderate-severe dementia;

DBS/MRgFUS/neurosurgery within 6 months;

Severe comorbidities limiting test

Trial design

Treatments tested in this trial

No Intervention: Observational Cohort

Treatment groups

100 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Taipei Medical University Shuang Ho Hospital

Lead sponsor

Source ClinicalTrials.gov